Volume 9, Number 1, January 2003

Cost Effectiveness of a Potential Vaccine for Human papillomavirus

Gillian D. Sanders* and Al V. Taira*
*Stanford University, Stanford, California, USA

Figure 5. Sensitivity analysis: frequency of Pap tests in vaccinated women. Effect of changing the frequency with which vaccinated women receive a Pap test. The diamonds represent Pap testing vaccinated women annually, every 2 years (base case), every 3 years, every 4 years, and every 5 years. The x-axis represents the lifetime expected cost of the vaccination strategy; the y-axis is the quality-adjusted life expectancy in years. The incremental cost effectiveness of increasing the frequency of Pap testing for vaccinated women is indicated numerically above the cost-effectiveness frontier.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed March 20, 2003

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention